DUCATION PRACTICE Critical Evaluation of Serologic Markers for Inflammatory Bowel isease

نویسندگان

  • REGORY L. AUSTIN
  • HANS H. HERFARTH
  • ROBERT S. SANDLER
چکیده

t p S b t Clinical Scenario A 44-year-old woman with abdominal pain of 4 onths’ duration is referred to your gastroenterology clinic rom her primary care physician for evaluation of positive erologic markers for IBD. The patient denies diarrhea, bright ed blood per rectum, melena, fevers, and weight loss. She has ormal liver function test results, complete blood count, erythocyte sedimentation rate, and C-reactive protein. There is no amily history of IBD. She has undergone an upper endoscopy, colonoscopy, and a small bowel series, all of which have been ormal. How do you proceed with evaluation and management of his patient? How should the information provided by the ositive serologic markers be used? What is the role of serologic arkers in the diagnosis of IBD?

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Compared With Elevated Erythrocyte Sedimentation Rate and Anemia Use of Serologic Markers as a Screening Tool in Inflammatory Bowel Disease

OBJECTIVES. The purpose of this work was to evaluate the use of serologic testing as a screening test for inflammatory bowel disease compared with erythrocyte sedimentation rate and hemoglobin in a referred patient population with suspected inflammatory bowel disease. PATIENTS AND METHODS.A retrospective study was performed, reviewing medical charts of patients who had inflammatory bowel diseas...

متن کامل

Utility of serological markers in inflammatory bowel diseases: gadget or magic?

The panel of serologic markers for inflammatory bowel diseases (IBD) is rapidly expanding. Although anti-Saccharomyces cerevisiae antibodies (ASCA) and atypical perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) remain the most widely investigated, an increasing amount of experimental data is available on newly discovered antibodies directed against various microbial antigens. The role ...

متن کامل

Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic

Background: Inflammatory bowel disease (IBD) involves chronic inflammation of the digestive tract. In the past decades, fecal calprotectin has been proposed as a useful biomarker for the differential diagnosis between IBD patients and healthy controls. We designed this study to evaluate the diagnostic ability of fecal calprotectin (FC) and conventional inflammatory markers in IBD patients. M...

متن کامل

Using Markers in IBD to Predict Disease and Treatment Outcomes: Rationale and a Review of Current Status

INTRODUCTION Th e appropriate management of patients with infl ammatory bowel disease (IBD) in 2016 incorporates the integration of biomarkers (fecal and serologic), radiology fi ndings, and endoscopic studies, together with clinical assessment. Although clinical assessment remains a critical part of patient care, these investigations can be used to identify patients with IBD, determine prognos...

متن کامل

Current and future role of serogenomics in ulcerative colitis.

Ulcerative colitis (UC), a chronic inflammatory bowel disease, occurs in genetically susceptible individuals who mount inappropriate immune responses to endoluminal antigens. Serologic and genetic markers have shown great potential for clinical application in Crohn's disease (CD), particularly for prognostication. However, their use is not as well established in UC. The aim of this paper is to ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2007